Memphis Pharmaceuticals announced the resignation of Dr. Osama Ibrahim Abdul Sattar, Chairman and Managing Director of the company, and the appointment of Dr. Amal Abdul Karim Abdul Wahid as Managing Director of the company as of July 10, 2017.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83.92 EGP | +0.66% | +0.64% | +33.82% |
1st Jan change | Capi. | |
---|---|---|
+33.82% | 10.01M | |
+37.27% | 727B | |
-7.90% | 354B | |
+15.44% | 328B | |
-0.57% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.81% | 164B | |
-2.15% | 164B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals Announces Executive Changes